MedTrace Logo

SORT OUT X - Combo Stent Versus ORSIRO Stent

NCT03216733 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3148

Last updated 2023-11-28

No results posted yet for this study

Summary

The aim of the Danish Organisation for randomised trials with clinical outcome (SORT OUT) is to compare the safety and efficacy of the ComboTM stent and Orsiro™ stent in the treatment of unselected patients with ischemic heart disease, using registry detection of clinically driven events.

Conditions

Interventions

DEVICE

COMBO

PCI with COMBO stent

DEVICE

ORSIRO

PCI with ORSIRO stent

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    collaborator INDUSTRY

  • OrbusNeich

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Lars Jakobsen, MD · Aarhus University Hospital Skejby

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-11-30
Completion
2028-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03216733 on ClinicalTrials.gov